[{"path":[]},{"path":"https://sigven.github.io/oncoPharmaDB/CODE_OF_CONDUCT.html","id":"our-pledge","dir":"","previous_headings":"","what":"Our Pledge","title":"Contributor Covenant Code of Conduct","text":"members, contributors, leaders pledge make participation community harassment-free experience everyone, regardless age, body size, visible invisible disability, ethnicity, sex characteristics, gender identity expression, level experience, education, socio-economic status, nationality, personal appearance, race, religion, sexual identity orientation. pledge act interact ways contribute open, welcoming, diverse, inclusive, healthy community.","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/CODE_OF_CONDUCT.html","id":"our-standards","dir":"","previous_headings":"","what":"Our Standards","title":"Contributor Covenant Code of Conduct","text":"Examples behavior contributes positive environment community include: Demonstrating empathy kindness toward people respectful differing opinions, viewpoints, experiences Giving gracefully accepting constructive feedback Accepting responsibility apologizing affected mistakes, learning experience Focusing best just us individuals, overall community Examples unacceptable behavior include: use sexualized language imagery, sexual attention advances kind Trolling, insulting derogatory comments, personal political attacks Public private harassment Publishing others’ private information, physical email address, without explicit permission conduct reasonably considered inappropriate professional setting","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/CODE_OF_CONDUCT.html","id":"enforcement-responsibilities","dir":"","previous_headings":"","what":"Enforcement Responsibilities","title":"Contributor Covenant Code of Conduct","text":"Community leaders responsible clarifying enforcing standards acceptable behavior take appropriate fair corrective action response behavior deem inappropriate, threatening, offensive, harmful. Community leaders right responsibility remove, edit, reject comments, commits, code, wiki edits, issues, contributions aligned Code Conduct, communicate reasons moderation decisions appropriate.","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/CODE_OF_CONDUCT.html","id":"scope","dir":"","previous_headings":"","what":"Scope","title":"Contributor Covenant Code of Conduct","text":"Code Conduct applies within community spaces, also applies individual officially representing community public spaces. Examples representing community include using official e-mail address, posting via official social media account, acting appointed representative online offline event.","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/CODE_OF_CONDUCT.html","id":"enforcement","dir":"","previous_headings":"","what":"Enforcement","title":"Contributor Covenant Code of Conduct","text":"Instances abusive, harassing, otherwise unacceptable behavior may reported community leaders responsible enforcement [INSERT CONTACT METHOD]. complaints reviewed investigated promptly fairly. community leaders obligated respect privacy security reporter incident.","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/CODE_OF_CONDUCT.html","id":"enforcement-guidelines","dir":"","previous_headings":"","what":"Enforcement Guidelines","title":"Contributor Covenant Code of Conduct","text":"Community leaders follow Community Impact Guidelines determining consequences action deem violation Code Conduct:","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/CODE_OF_CONDUCT.html","id":"1-correction","dir":"","previous_headings":"Enforcement Guidelines","what":"1. Correction","title":"Contributor Covenant Code of Conduct","text":"Community Impact: Use inappropriate language behavior deemed unprofessional unwelcome community. Consequence: private, written warning community leaders, providing clarity around nature violation explanation behavior inappropriate. public apology may requested.","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/CODE_OF_CONDUCT.html","id":"2-warning","dir":"","previous_headings":"Enforcement Guidelines","what":"2. Warning","title":"Contributor Covenant Code of Conduct","text":"Community Impact: violation single incident series actions. Consequence: warning consequences continued behavior. interaction people involved, including unsolicited interaction enforcing Code Conduct, specified period time. includes avoiding interactions community spaces well external channels like social media. Violating terms may lead temporary permanent ban.","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/CODE_OF_CONDUCT.html","id":"3-temporary-ban","dir":"","previous_headings":"Enforcement Guidelines","what":"3. Temporary Ban","title":"Contributor Covenant Code of Conduct","text":"Community Impact: serious violation community standards, including sustained inappropriate behavior. Consequence: temporary ban sort interaction public communication community specified period time. public private interaction people involved, including unsolicited interaction enforcing Code Conduct, allowed period. Violating terms may lead permanent ban.","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/CODE_OF_CONDUCT.html","id":"4-permanent-ban","dir":"","previous_headings":"Enforcement Guidelines","what":"4. Permanent Ban","title":"Contributor Covenant Code of Conduct","text":"Community Impact: Demonstrating pattern violation community standards, including sustained inappropriate behavior, harassment individual, aggression toward disparagement classes individuals. Consequence: permanent ban sort public interaction within community.","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/CODE_OF_CONDUCT.html","id":"attribution","dir":"","previous_headings":"","what":"Attribution","title":"Contributor Covenant Code of Conduct","text":"Code Conduct adapted Contributor Covenant, version 2.0, available https://www.contributor-covenant.org/version/2/0/ code_of_conduct.html. Community Impact Guidelines inspired Mozilla’s code conduct enforcement ladder. answers common questions code conduct, see FAQ https://www.contributor-covenant.org/faq. Translations available https:// www.contributor-covenant.org/translations.","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Sigve Nakken. Author, maintainer.","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Nakken S.  (2022)  oncoPharmaDB: Targeted non-targeted anti-cancer drugs drug regimens.  R package version 0.8.4.  (https://github.com/sigven/oncoPharmaDB)","code":"@Manual{,   title = {oncoPharmaDB: Targeted and non-targeted anti-cancer drugs and drug regimens},   author = {Sigve Nakken},   year = {2022},   note = {R package version 0.8.4},   url = {https://github.com/sigven/oncoPharmaDB}, }"},{"path":"https://sigven.github.io/oncoPharmaDB/index.html","id":"oncopharmadb---targeted-and-non-targeted-anticancer-drugs-and-drug-regimens","dir":"","previous_headings":"","what":"oncoPharmaDB - Targeted and non-targeted anticancer drugs and drug regimens","title":"Dataset with targeted and non-targeted anticancer drugs","text":"R package provides dataset method query targeted non-targeted cancer drugs, including comprehensive annotations per target, drug mechanism--action, approval dates, clinical trial phases various indications etc. main dataset largely based drug-target-indication associations provided Open Targets Platform (Ochoa et al., Nucleic Acids Res., 2021), limited associations cancer-relevant indications (provided sigven/oncoPhenoMap). Drug-target associations Open Targets Platform furthermore integrated drug information NCI Thesaurus, append non-targeted cancer drugs (chemotherapies etc.) different drug regimens. oncoPharmaDB also provides drug biomarkers, curated databases CIViC, CGI Anti-cancer drugs currently provided following tentative drug categories/types (necessarily mutually exclusive), indicative mechanism--action: Alkylating agents Angiogenesis inhibitors Anthracyclines Antimetabolites AR antagonists BET inhibitors Hedgehog antagonists HDAC inhibitors Hormone therapies Immune checkpoint inhibitors Kinase inhibitors Monoclonal antibodies PARP inhibitors Platinum compounds Proteasome inhibitors Topoisomerase inhibitors Tubulin inhibitors Currently (July 27th 2022), oncoPharmaDB built upon following releases external databases: Open Targets Platform (2022.06) ChEMBL (v30) NCI Thesaurus (22.07d)","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/index.html","id":"getting-started","dir":"","previous_headings":"oncoPharmaDB - Targeted and non-targeted anticancer drugs and drug regimens","what":"Getting started","title":"Dataset with targeted and non-targeted anticancer drugs","text":"Installation instructions Usage examples","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/index.html","id":"contact","dir":"","previous_headings":"oncoPharmaDB - Targeted and non-targeted anticancer drugs and drug regimens","what":"Contact","title":"Dataset with targeted and non-targeted anticancer drugs","text":"sigven ifi.uio.","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/index.html","id":"code-of-conduct","dir":"","previous_headings":"oncoPharmaDB - Targeted and non-targeted anticancer drugs and drug regimens","what":"Code of Conduct","title":"Dataset with targeted and non-targeted anticancer drugs","text":"Please note project released Contributor Code Conduct. participating project agree abide terms.","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/reference/compound_biomarkers.html","id":null,"dir":"Reference","previous_headings":"","what":"Datasets of compound biomarkers - omics properties that are linked to drug response — compound_biomarkers","title":"Datasets of compound biomarkers - omics properties that are linked to drug response — compound_biomarkers","text":"Datasets compound biomarkers - omics properties linked drug response","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/reference/compound_biomarkers.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Datasets of compound biomarkers - omics properties that are linked to drug response — compound_biomarkers","text":"","code":"compound_biomarkers"},{"path":"https://sigven.github.io/oncoPharmaDB/reference/compound_biomarkers.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Datasets of compound biomarkers - omics properties that are linked to drug response — compound_biomarkers","text":"curated - data frame 288,922 rows 26 columns: evidence_id - evidence identifier evidence_url - evidence URL variant_id - variant identifier variant_type - type variant variant - variant (alias) alteration_type - type genetic alteration symbol - drug target (gene symbol) therapeutic_context - therapeutic context (drug sensitivity/resistance) disease_ontology_id - disease ontology () identifier (mapped - oncoPhenoMap) cancer_type - tumor type/disease (provided source) molecule_chembl_id - ChEMBL compound identifier citation_id - citation identifier (PMID etc) evidence_description - evidence description evidence_type - evidence type evidence_level - evidence level evidence_direction - evidence direction clinical_significance - clinical significance variant_origin - variant origin (somatic/germline) biomarker_source_db - type biomarker source database biomarker_entity - logical indicating biomarker entity efo_id - EFO identifier (mapped - oncoPhenoMap) efo_name - EFO name (mapped - oncoPhenoMap) do_name - disease ontology () name (mapped - oncoPhenoMap) cui - disease UMLS identifier (mapped - oncoPhenoMap) cui_name - disease UMLS name (mapped - oncoPhenoMap) primary_site - primary tumor site (mapped - oncoPhenoMap) invitro_screen - data frame 25,763 rows 8 columns: compound_id - compound identifier (PRISM) model - type omics drug prediction model (DepMap/PRISM) feature_type - type omics feature feature_value - value omics feature feature_importance - omics feature importance prediction_accuracy - model prediction accuracy nci_concept_display_name - Primary drug name (NCI Thesaurus) molecule_chembl_id - ChEMBL compound identifier","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/reference/compound_biomarkers.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Datasets of compound biomarkers - omics properties that are linked to drug response — compound_biomarkers","text":"https://civicdb.org/ https://www.cancergenomeinterpreter.org/biomarkers https://pmkb.weill.cornell.edu/ https://mitelmandatabase.isb-cgc.org/ https://depmap.org/portal/","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/reference/compound_synonyms.html","id":null,"dir":"Reference","previous_headings":"","what":"Dataset of compound synonyms - linking known drug aliases to a primary identifier (ChEMBL) — compound_synonyms","title":"Dataset of compound synonyms - linking known drug aliases to a primary identifier (ChEMBL) — compound_synonyms","text":"Dataset compound synonyms - linking known drug aliases primary identifier (ChEMBL)","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/reference/compound_synonyms.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Dataset of compound synonyms - linking known drug aliases to a primary identifier (ChEMBL) — compound_synonyms","text":"","code":"compound_synonyms"},{"path":"https://sigven.github.io/oncoPharmaDB/reference/compound_synonyms.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Dataset of compound synonyms - linking known drug aliases to a primary identifier (ChEMBL) — compound_synonyms","text":"compound_synonyms - data frame 507,661 rows 3 columns: alias - drug alias nci_concept_display_name - Primary drug name (NCI Thesaurus) molecule_chembl_id - ChEMBL compound identifier","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/reference/compound_synonyms.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Dataset of compound synonyms - linking known drug aliases to a primary identifier (ChEMBL) — compound_synonyms","text":"https://targetvalidation.org/ https://www.ebi.ac.uk/chembl/ https://ncithesaurus.nci.nih.gov/ncitbrowser/","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/reference/get_onco_drugs.html","id":null,"dir":"Reference","previous_headings":"","what":"Retrieve antineoplastic drugs and drug regimens — get_onco_drugs","title":"Retrieve antineoplastic drugs and drug regimens — get_onco_drugs","text":"Retrieve antineoplastic drugs drug regimens","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/reference/get_onco_drugs.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Retrieve antineoplastic drugs and drug regimens — get_onco_drugs","text":"","code":"get_onco_drugs(   drug_is_targeted = F,   drug_is_approved = F,   drug_target = NULL,   drug_action_type = NULL,   drug_indication_main = NULL,   source_opentargets_only = F,   drug_has_blackbox_warning = F,   drug_approved_later_than = 1939,   drug_minimum_phase_any_indication = 0,   list_per_drug_synonym = F,   output_resolution = \"drug2target2indication\",   output_style = \"extensive\",   is_alkylating_agent = F,   is_angiogenesis_inhibitor = F,   is_anthracycline = F,   is_antimetabolite = F,   is_ar_antagonist = F,   is_bet_inhibitor = F,   is_hedgehog_antagonist = F,   is_hdac_inhibitor = F,   is_hormone_therapy = F,   is_immune_checkpoint_inhibitor = F,   is_kinase_inhibitor = F,   is_monoclonal_antibody = F,   is_parp_inhibitor = F,   is_platinum_compound = F,   is_proteasome_inhibitor = F,   is_topoisomerase_inhibitor = F,   is_tubulin_inhibitor = F )"},{"path":"https://sigven.github.io/oncoPharmaDB/reference/get_onco_drugs.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Retrieve antineoplastic drugs and drug regimens — get_onco_drugs","text":"drug_is_targeted logical indicating resulting drug records contain molecularly targeted drugs drug_is_approved logical indicating resulting drug records contain approved drugs drug_target character vector drug targets (gene symbols) drug records included results drug_action_type character vector drug action types include drug record list - possible values \"INHIBITOR\",\"AGONIST\",\"MODULATOR\",\"ANTAGONIST\",\"BLOCKER\",\"ACTIVATOR\",\"BINDING AGENT\",\"OPENER\", \"STABILISER\",\"CROSS-LINKING AGENT\",DISRUPTING AGENT\",\"\" drug_indication_main character vector main tumor types drug(s) indicated possible values \"Adrenal Gland\",\"Biliary Tract\",\"Bladder/Urinary Tract\",\"Bone\",\"Breast\",\"Cervix\",\"CNS/Brain\", \"Colon/Rectum\",\"Esophagus/Stomach\",\"Eye\",\"Head Neck\",\"Kidney\",\"Liver\",\"Lung\",\"Lymphoid\",\"Myeloid\",\"Ovary/Fallopian Tube\", \"Pancreas\",\"Penis\",\"Peripheral Nervous System\",\"Peritoneum\",\"Pleura\",\"Prostate\",\"Skin\",\"Soft Tissue\",\"Testis\",\"Thymus\", \"Thyroid\",\"Uterus\",\"Vulva/Vagina\" source_opentargets_only logical indicating resulting drug records contain drug records Open Targets Platform drug_has_blackbox_warning logical indicating resulting drug records contain drugs black box warnings drug_approved_later_than include records drugs approved later date (year) drug_minimum_phase_any_indication include drug records clinical phase (indication) greater equal phase list_per_drug_synonym list resulting drug records per drug synonym output_resolution output record resolution ('drug','drug2target','drug2target2indication') output_style comprehensiveness drug records ('extensive' - annotations, 'narrow' - main annotations) is_alkylating_agent logical indicating drug class wanted is_angiogenesis_inhibitor logical indicating drug class wanted is_anthracycline logical indicating drug class wanted is_antimetabolite logical indicating drug class wanted is_ar_antagonist logical indicating drug class wanted is_bet_inhibitor logical indicating drug class wanted is_hedgehog_antagonist logical indicating drug class wanted is_hdac_inhibitor logical indicating drug class wanted is_hormone_therapy logical indicating drug class wanted is_immune_checkpoint_inhibitor logical indicating drug class wanted is_kinase_inhibitor logical indicating drug class wanted is_monoclonal_antibody logical indicating drug class wanted is_parp_inhibitor logical indicating drug class wanted is_platinum_compound logical indicating drug class wanted is_proteasome_inhibitor logical indicating drug class wanted is_topoisomerase_inhibitor logical indicating drug class wanted is_tubulin_inhibitor logical indicating drug class wanted","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/reference/oncopharmadb.html","id":null,"dir":"Reference","previous_headings":"","what":"Dataset of targeted and non-targeted cancer drugs — oncopharmadb","title":"Dataset of targeted and non-targeted cancer drugs — oncopharmadb","text":"dataset containing extensive collection anti-cancer drugs, .e. targeted compounds, chemotherapy regimens etc. data harvested Open Targets Platform, NCI Thesaurus, ChEMBL. Note entry corresponds \"drug synonym-target-indication association\"","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/reference/oncopharmadb.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Dataset of targeted and non-targeted cancer drugs — oncopharmadb","text":"","code":"oncopharmadb"},{"path":"https://sigven.github.io/oncoPharmaDB/reference/oncopharmadb.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Dataset of targeted and non-targeted cancer drugs — oncopharmadb","text":"oncopharmadb - data frame 556,467 rows 49 columns: drug_name - Primary drug name (upper case, NCI Thesaurus) nci_concept_display_name - Primary drug name (NCI Thesaurus) drug_type - type drug molecule (Antibody, small molecule etc) drug_action_type - main action elicited drug (antagonist, inhibitor, stabiliser etc) molecule_chembl_id - ChEMBL compound identifier drug_max_phase_indication - maximum clinical phase drug (given indication) drug_max_ct_phase - maximum clinical phase drug (indication) target_genename - name/description drug target target_symbol - symbol drug target target_type - type drug target (single protein, protein family etc.) target_ensembl_gene_id - Ensembl gene identifier drug target target_entrezgene - Entrez gene identifier drug target target_uniprot_id - UniProt identifier drug target disease_efo_id - EFO (Experimental Factor Ontology) identifier drug indication disease_efo_label - EFO (Experimental Factor Ontology) label drug indication cui - UMLS metathesaurus identifier (concept unique identifier) drug indication cui_name - UMLS metahesaurus name drug indication primary_site - primary tumor site/type (obtained https://github.com/sigven/oncoPhenoMap) nci_concept_synonym - drug synonym (NCI, Open Targets Platform) nci_concept_synonym_all - drug synonyms (NCI Thesurus, Open Targets Platform) drug_clinical_source - underlying source drug entry (DailyMed, clinicaltrials.gov, FDA etc.) drug_approved_indication - logical indicating drug approved indication drug_blacbox_warning - logical indicating drug blackbox warning drug_year_first_approval - year drug first approved drug_clinical_id - drug clinical identifier (clinicaltrials.gov, DailyMed, FDA etc.) nci_t - NCI Thesaurus identifier nci_concept_definition - detailed description drug mechanism--action (NCI Thesaurus) nci_version - version NCI used version oncoPharmaDB chembl_version - version ChEMBL used version oncoPharmaDB opentargets_version - version Open Target Platform used version oncoPharmaDB comb_regimen_indication - logical whether use drug given condition context drug combination immune_checkpoint_inhibitor - logical indicating drug immune checkpoint inhibitor topoisomerase_inhibitor - logical indicating drug topoisomerase inhibitor tubulin_inhibitor - logical indicating drug tubulin inhibitor kinase_inhibitor - logical indicating drug kinase inhibitor hdac_inhibitor - logical indicating drug HDAC inhibitor parp_inhibitor - logical indicating drug PARP inhibitor bet_inhibitor - logical indicating drug BET inhibitor ar_antagonist - logical indicating drug androgen receptor antagonist monoclonal_antibody - logical indicating drug antibody antimetabolite - logical indicating drug antimetabolite angiogenesis_inhibitor - logical indicating drug angiogenesis inhibitor alkylating_agent - logical indicating drug alkylating agent platinum_compound - logical indicating drug platinum compound anthracycline - logical indicating drug anthracycline proteasome_inhibitor - logical indicating drug proteasome inhibitor hormone_therapy - logical indicating drug hormone therapy hedgehog_antagonist - logical indicating drug hedgehog pathway antagonist fda_epc_category - FDA Established Pharmacologic Class (EPC) text phrase","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/reference/oncopharmadb.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Dataset of targeted and non-targeted cancer drugs — oncopharmadb","text":"https://targetvalidation.org/ https://www.ebi.ac.uk/chembl/ https://ncithesaurus.nci.nih.gov/ncitbrowser/","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/reference/pipe.html","id":null,"dir":"Reference","previous_headings":"","what":"Pipe operator — %>%","title":"Pipe operator — %>%","text":"See magrittr::%>% details.","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/reference/targets.html","id":null,"dir":"Reference","previous_headings":"","what":"Dataset of therapeutic and actionable targets in cancer — targets","title":"Dataset of therapeutic and actionable targets in cancer — targets","text":"list two data frames: druggable: data frame indicates drugs/compounds pr. target actionable: data frame actionable genes cancer (biomarkers , therapies, prognosis etc. (harvested various sources)","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/reference/targets.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Dataset of therapeutic and actionable targets in cancer — targets","text":"","code":"targets"},{"path":"https://sigven.github.io/oncoPharmaDB/reference/targets.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Dataset of therapeutic and actionable targets in cancer — targets","text":"druggable - data frame 1,094 rows 6 columns: symbol - Gene symbol ensembl_gene_id - Ensembl gene identifier genename - Gene description entrezgene - Gene identifier (Entrez) nci_concept_display_name - Primary compound name (separated '|') molecule_chembl_id - ChEMBL compound identifier (separated '|') actionable - data frame 623 rows 7 columns: symbol - Gene symbol ensembl_gene_id - Ensembl gene identifier genename - Gene description entrezgene - Gene identifier (Entrez) phenotypes - List associated phenotypes actionable gene clinical_significance - Clinical significance biomarker (prognosis, drug sensitivity etc) source_db - Underlying source database actionability evidence","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/reference/tidyeval.html","id":null,"dir":"Reference","previous_headings":"","what":"Tidy eval helpers — tidyeval","title":"Tidy eval helpers — tidyeval","text":"https://cran.r-project.org/web/packages/dplyr/vignettes/programming.html","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/news/index.html","id":"version-084-july-27th-2022","dir":"Changelog","previous_headings":"","what":"Version 0.8.4 (July 27th 2022)","title":"Version 0.8.4 (July 27th 2022)","text":"Updated NCI Thesaurus (22.07d) Updated biomarkers (CIViC/Mitelman database)","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/news/index.html","id":"version-083-july-1st-2022","dir":"Changelog","previous_headings":"","what":"Version 0.8.3 (July 1st 2022)","title":"Version 0.8.3 (July 1st 2022)","text":"Updated NCI Thesaurus (22.06d) Updated Open Targets Platform (2022.06) Updated biomarkers (CIViC)","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/news/index.html","id":"version-082-june-19th-2022","dir":"Changelog","previous_headings":"","what":"Version 0.8.2 (June 19th 2022)","title":"Version 0.8.2 (June 19th 2022)","text":"Added drugs NCI thesaurus Drug indication updates: (EFO/- https://github.com/sigven/oncoPhenoMap) Updated biomarkers (CIViC)","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/news/index.html","id":"version-081-june-2nd-2022","dir":"Changelog","previous_headings":"","what":"Version 0.8.1 (June 2nd 2022)","title":"Version 0.8.1 (June 2nd 2022)","text":"Data updates: NCI Thesaurus (22.05e)","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/news/index.html","id":"version-080-may-31st-2022","dir":"Changelog","previous_headings":"","what":"Version 0.8.0 (May 31st 2022)","title":"Version 0.8.0 (May 31st 2022)","text":"Updated indication matching data https://github.com/sigven/oncoPhenoMap","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/news/index.html","id":"version-076-april-22nd-2022","dir":"Changelog","previous_headings":"","what":"Version 0.7.6 (April 22nd 2022)","title":"Version 0.7.6 (April 22nd 2022)","text":"Fixed ambiguous synonym entries (paclitaxel, cisplatin, seribantumab, trastuzumab emtansine) Updated indication matching data https://github.com/sigven/oncoPhenoMap (v0.3.2) Updated biomarker collection (MitelmanDB - April 2022 release) + CIViC (April 22nd 2022)","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/news/index.html","id":"version-072-march-30th-2022","dir":"Changelog","previous_headings":"","what":"Version 0.7.2 (March 30th 2022)","title":"Version 0.7.2 (March 30th 2022)","text":"Fixed bug installation documentation","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/news/index.html","id":"version-071-march-30th-2022","dir":"Changelog","previous_headings":"","what":"Version 0.7.1 (March 30th 2022)","title":"Version 0.7.1 (March 30th 2022)","text":"Data updates: NCI Thesaurus (22.03d) Updated biomarkers (CIViC)","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/news/index.html","id":"version-070-march-4th-2022","dir":"Changelog","previous_headings":"","what":"Version 0.7.0 (March 4th 2022)","title":"Version 0.7.0 (March 4th 2022)","text":"Data updates: NCI Thesaurus (22.02d), Open Targets Platform (2022.02)","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/news/index.html","id":"version-069-february-8th-2022","dir":"Changelog","previous_headings":"","what":"Version 0.6.9 (February 8th 2022)","title":"Version 0.6.9 (February 8th 2022)","text":"Data update: NCI Thesaurus (22.01e) Added FDA pharmacologic class (established pharmacological class - EPC) phrases oncopharmadb data.frame","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/news/index.html","id":"version-066-january-17th-2022","dir":"Changelog","previous_headings":"","what":"Version 0.6.6 (January 17th 2022)","title":"Version 0.6.6 (January 17th 2022)","text":"Fixed duplicate column oncopharmadb (immune checkpoint inhibitor) Updated biomarkers (CIViC)","code":""},{"path":"https://sigven.github.io/oncoPharmaDB/news/index.html","id":"version-065-january-4th-2022","dir":"Changelog","previous_headings":"","what":"Version 0.6.5 (January 4th 2022)","title":"Version 0.6.5 (January 4th 2022)","text":"Data update: NCI Thesaurus (21.12d) Renamed exported dataset oncopharma_synonyms -> compound_synonyms Added datasets compound biomarkers, curated (CIViC/CGI/PMKB, oncoPharmaDB::compound_biomarkers[[‘curated’]]), data invitro drug screens (DepMap/PRISM, oncoPharmaDB::compound_biomarkers[[‘invitro_screen’]])","code":""}]
